Medical Complications in Lung Transplant Recipients with Pulmonary FibrosisKamyar Afshar*, Ngozi Orjioke, and Timothy Whelan
Division of Pulmonary and Critical Care, University of Southern California, Keck School of Medicine, USA
- *Corresponding Author:
- Kamyar Afshar
Assistant Professor of Clinical Medicine
University of Southern California
Keck School of Medicine
Division of Pulmonary and Critical Care
2020 Zonal Ave, IRD 723, Los Angeles, CA 90033
E-mail: [email protected]
Received date: February 14, 2013; Accepted date: April 02, 2013; Published date: April 05, 2013
Citation: Afshar K, Orjioke N, Whelan T (2013) Medical Complications in Lung Transplant Recipients with Pulmonary Fibrosis. J Pulmon Resp Med 3:145. doi: 10.4172/2161-105X.1000145
Copyright: © 2013 Afshar K, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Lung transplantation is a therapeutic option for selected patients with severe interstitial disease who continue to have progressive clinical deterioration. There is a survival advantage for selected patients who undergo transplant, but it primarily improves quality of life after transplantation. Unfortunately, patients with IPF have worse outcomes following lung transplantation due to various factors. This review article will describe several common postoperative complications including an astamotic complications, allograft dysfunction, cardiovascular complications, thromboembolic phenomenon, renal failure, neurologic complications and complications related to the native lung in the single lung transplant recipients.